- Product Details
Keywords
- 1379686-30-2
- SR9009 Powder
- STENABOLIC
Quick Details
- ProName: SR9009 Powder
- CasNo: 1379686-30-2
- Molecular Formula: C20H24ClN3O4S
- Appearance: White or almost white crystalline powd...
- Application: Pharmaceutical intermediates
- DeliveryTime: With three or five working days
- PackAge: 25kg/fiber drum, sealed package
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.9%
- Storage: Sealed package
- Transportation: Sealed container
- LimitNum: 1 Kilogram
- Residue on Ignition: ≤ 0.2 %
- Heavy Metal: ≤ 20ppm
- Valid Period: 2020-12-18
Superiority
1. Advanced facility and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
Name: SR9009 Powder
CAS No: 1379686-30-2
Molecular Formular: C20H24ClN3O4S
Molecular Weight: 437.94026
Appearance: White fine powder
Solubility: insoluble in water
SR9009 is one of a pair of compounds developed at TSRI by Burris and his team. The drug binds to Rev-erbα, a natural protein in the body that influences lipid and glucose metabolism in the liver, inflammatory responses, and fat-storing cells. By binding to Rev-erbα, SR9009 can kickstart metabolism with another pleasant side-effect: increased muscle strength.
Now, after modulating Rev-erbα's activity with drugs, studies have shown its direct effect on skeletal muscles.
With such strong results, Burris and his team are pursuing funding for a biotechnology company that would focus primarily on the development of SR9009 and other similar compounds for safe use in humans.